An observational study in Broncho Pulmonary Cancer, sponsored by Institut de Cancérologie de la Loire. Status unknown at 2 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-14.
Sponsored by Institut de Cancérologie de la Loire · Observational
The main objective is to identify obstacles and elements facilitating the implementation of a tracking device Broncho Pulmonary Cancer during the course of care.
The secondary objective is to assess patient knowledge and information received on their previous occupational exposure during their professional activity.
This is a prospective multicenter study of qualitative methodology through in-depth interviews conducted with patients treated at ICLN and CHU Saint-Etienne
7,243 studies on the registry are indexed under Lung Neoplasms; 1,557 are open to participants now.
This study's planned enrollment of 20 is below the median of 189 across 1,514 observational studies indexed under Lung Neoplasms.
Browse Lung Neoplasms studies →Institut de Cancérologie de la Loire is the lead sponsor of 28 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
primitive CBP Patients
Exclusion Criteria:
The questionnaire is tracking occupational carcinogens. It consists of 30 questions , fills an average of 3 minutes and includes three response categories: "yes", "no" and "do not know". A questionnaire will be added social and professional issues. Interviews will be conducted with the patient to identify obstacles and facilitating elements
Behavioral: questionnaire
Interview
Obstacles and elements facilitating the establishment of a work-related bronchopulmonary cancer tracking device during the course of care. These are collected in an interview with a sociologist. It will be analyse with NVivo.
Time frame: 45 minutes
This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Institut de Cancérologie de la Loire